- Report
- March 2024
- 197 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- April 2024
- 194 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Clinical Trials
- January 2024
- 120 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Report
- March 2024
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- August 2023
- 118 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- October 2023
- 178 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- January 2022
- 120 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- September 2021
- 40 Pages
China
From €2513EUR$2,600USD£2,160GBP
- Report
- March 2018
- 33 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Report
- March 2018
- 34 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Drug Pipelines
- January 2018
- 10 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Report
- March 2018
- 35 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Drug Pipelines
- March 2018
- 56 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Report
- July 2023
- 133 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- April 2024
- 98 Pages
From €3500EUR$3,878USD£3,114GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- March 2022
- 101 Pages
Global
From €3500EUR$3,878USD£3,114GBP
Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes.
The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more